Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 22, 2018

DrugPatentWatch Database Preview

Jubilant Cadista Company Profile

« Back to Dashboard

What is the competitive landscape for JUBILANT CADISTA, and what generic and branded alternatives to JUBILANT CADISTA drugs are available?

JUBILANT CADISTA has nineteen approved drugs.

Summary for Jubilant Cadista

US Patents:	0
Tradenames:	17
Ingredients:	16
NDAs:	19
Patent Litigation for Jubilant Cadista:	See patent lawsuits for Jubilant Cadista

Drugs and US Patents for Jubilant Cadista

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Jubilant Cadista	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	090557-001	Feb 18, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Jubilant Cadista	RISPERIDONE	risperidone	TABLET;ORAL	078828-005	Mar 23, 2009		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Jubilant Cadista	RISPERIDONE	risperidone	TABLET;ORAL	078828-001	Mar 23, 2009		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Jubilant Cadista	MECLIZINE HYDROCHLORIDE	meclizine hydrochloride	TABLET;ORAL	040659-001	Jun 4, 2010	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson

Express Scripts

Baxter

Julphar

Merck

Queensland Health

US Army

Johnson and Johnson

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.